DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "China Human Vaccine Industry Report, 2016-2020" report to their offering.
Amid the unsafe domestic vaccine events, China's human vaccine lot release volume in 2015 fell by 17.9% year on year to only 650 million doses, touching a 5-year low. Moreover, with the improvements in domestic vaccine supply capacity and vaccine circulation safety, China's human vaccine import volume has showed a year-by-year decline in recent years, with the imports for 2015 totaling 173.9 tons, down 17.5%.
Affected by China's less-developed economy, existing national vaccine prevention policies and people's awareness of epidemic prevention, free EPI vaccines prevail in China. But the market share is falling, with the free EPI vaccine lot release volume in 2015 accounting for about 74.3% of the total.
The Chinese free human vaccine market is still dominated by the subsidiaries of China National Biotec Group. However, as China gradually relaxes controls on the vaccine market, private companies have unexpectedly emerged in the extra EPI vaccine market segment in recent years, with the proportion increasing constantly. In 2015, their lot release volume accounted for 70% in this market segment.
Being upbeat about China's human vaccine demand market and exports, many vaccine producers are stepping up vaccine R&D or expanding capacity.
Key Topics Covered:
1. Overview of Vaccine Industry
2. China Human Vaccine Industry & Market
3. Human Vaccine Market Segments in China
4. China's Import and Export of Vaccines
5. Major Vaccine Manufacturers in China
Companies Mentioned:
- Beijing Minhai Biotechnology Co., Ltd.
- Beijing Tiantan Biological Products Co., Ltd
- Changchun BCHT Biotechnology Co. Ltd.
- Changchun Changsheng Life Sciences Limited
- Changchun Institute of Biological Products Co., Ltd.
- Chengdu Institute of Biological Products Co., Ltd.
- China National Biotec Group
- Chongqing Zhifei Biological Products Co., Ltd.
- Dalian Aleph Biomedical Co., Ltd.
- Dalian Hissen Bio-Pharm Co., Ltd.
- Hualan Biological Engineering Inc.
- Jiangsu SimcereVaxtec Bio-pharmaceutical Co., Ltd.
- Lanzhou Institute of Biological Products Co., Ltd.
- Liaoning Cheng Da Co., Ltd.
- Liaoning Chengda Biotechnology Co., Ltd.
- NCPC GeneTech Biotechnology Development Co., Ltd.
- Shanghai Institute of Biological Products Co., Ltd.
- Shenzhen Kangtai Biological Products Co. Ltd.
- Shenzhen Sanofi Pasteur Biological Products Co., Ltd.
- Sinovac Biotech Ltd.
- Walvax Biotechnology Co, Ltd.
- Wuhan Institute of Biological Products Co., Ltd.
- Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
For more information visit http://www.researchandmarkets.com/research/zkvvfl/china_human
